Contents

Current Pharmaceutical Design, Volume 17 - Number 10

Editorial [Hot topic:VIP and PACAP: Novel Approaches to Brain Functions and Neuroprotection (Executive Guest Editors: Seiji Shioda and Illana Gozes)]

, 17(10): 961

Seiji Shioda and Illana Gozes


DOI: 10.2174/138161211795589391




Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo

, 17(10): 962 - 972

D. Reglodi, P. Kiss, A. Lubics and A. Tamas


DOI: 10.2174/138161211795589355




Role of PACAP in Neural Stem/Progenitor Cell and Astrocyte: from Neural Development to Neural Repair

, 17(10): 973 - 984

Tomoya Nakamachi, Jozsef Farkas, Jun Watanabe, Hirokazu Ohtaki, Kenji Dohi, Satoru Arata and Seiji Shioda


DOI: 10.2174/138161211795589346




PACAP is Implicated in the Stress Axes

, 17(10): 985 - 989

Hitoshi Hashimoto, Norihito Shintani, Mamoru Tanida, Atsuko Hayata, Ryota Hashimoto and Akemichi Baba


DOI: 10.2174/138161211795589382




The Role of the PACAP Signaling System in Depression

, 17(10): 990 - 1001

Albert Pinhasov, Elimelech Nesher, Moshe Gross, Gadi Turgeman, Anatoly Kreinin and Gal Yadid


DOI: 10.2174/138161211795589328




Strategies to Convert PACAP from a Hypophysiotropic Neurohormone Into a Neuroprotective Drug

, 17(10): 1002 - 1024

S. Bourgault, D. Chatenet, O. Wurtz, N. D. Doan, J. Leprince, H. Vaudry, A. Fournier and D. Vaudry


DOI: 10.2174/138161211795589337




Immunomodulatory Roles of VIP and PACAP in Models of Multiple Sclerosis

, 17(10): 1025 - 1035

Catalina Abad and James A. Waschek


DOI: 10.2174/138161211795589364




VIP-induced Neuroprotection of the Developing Brain

, 17(10): 1036 - 1039

Sandrine Passemard, Paulina Sokolowska, Leslie Schwendimann and Pierre Gressens


DOI: 10.2174/138161211795589409




NAP (Davunetide) Provides Functional and Structural Neuroprotection

, 17(10): 1040 - 1044

Illana Gozes


DOI: 10.2174/138161211795589373




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science